| Product Code: ETC6575636 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Burkina Faso continues to rely on imports for non-alcoholic steatohepatitis treatment, with top suppliers being India, France, Ghana, Morocco, and China in 2024. Despite a slightly declining compound annual growth rate (CAGR) of -0.46% from 2020 to 2024, there was a notable growth rate of 10.24% in 2024. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI) in 2024. This data suggests ongoing demand for non-alcoholic steatohepatitis treatments in Burkina Faso, with key suppliers meeting the market needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market - Industry Life Cycle |
3.4 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market - Porter's Five Forces |
3.5 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Burkina Faso |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of NASH |
4.2.3 Improving healthcare infrastructure and access to healthcare services in Burkina Faso |
4.3 Market Restraints |
4.3.1 Limited availability of approved drugs specifically for NASH treatment in Burkina Faso |
4.3.2 High costs associated with NASH treatment and management |
4.3.3 Lack of specialized healthcare professionals for NASH diagnosis and treatment in Burkina Faso |
5 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Trends |
6 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market, By Types |
6.1 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F |
6.1.4 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Obeticholic Acid (OCA), 2021- 2031F |
6.1.5 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Lanifibranor, 2021- 2031F |
6.1.6 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Semaglutide, 2021- 2031F |
6.1.7 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Resmetirom, 2021- 2031F |
6.1.8 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Aramchol, 2021- 2031F |
6.1.9 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Retail and Specialty Pharmacies, 2021- 2031F |
6.2.4 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Import-Export Trade Statistics |
7.1 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Export to Major Countries |
7.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Imports from Major Countries |
8 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Key Performance Indicators |
8.1 Average time from NASH diagnosis to treatment initiation |
8.2 Number of healthcare facilities offering NASH diagnosis and treatment services |
8.3 Percentage of NASH patients receiving appropriate follow-up care |
8.4 Rate of adherence to NASH treatment regimens |
8.5 Number of clinical trials or research studies focused on NASH treatment in Burkina Faso |
9 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market - Opportunity Assessment |
9.1 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market - Competitive Landscape |
10.1 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Non-Alcoholic Steatohepatitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |